Noven Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.70 Cr
as on 17-12-2024
- Paid Up Capital ₹ 2.51 Cr
as on 17-12-2024
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.40 Cr
as on 17-12-2024
- Revenue -0.74%
(FY 2022)
- Profit 24.62%
(FY 2022)
- Ebitda -19.70%
(FY 2022)
- Net Worth 2.27%
(FY 2022)
- Total Assets -0.20%
(FY 2022)
About Noven Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.70 Cr and a paid-up capital of Rs 2.51 Cr.
The company currently has active open charges totaling ₹5.40 Cr.
Sai Gajjala, Bhagavatranga Gajjala, and Sireesha Gajjala serve as directors at the Company.
- CIN/LLPIN
U24110TG1991PTC012262
- Company No.
012262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Noven Life Sciences Private Limited offer?
Noven Life Sciences Private Limited offers a wide range of products and services, including Soaps, Detergent Powder & Cakes, Sodium Silicate, Pharma Ingredients & Raw Materials, Vitamin Powder API, Animal Medicines & Health Care, Anthelmintics, Veterinary Medicines, Antiallergic API, Chemical Reagents & Catalysts, Fatty Esters.
Who are the key members and board of directors at Noven Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sai Gajjala | Additional Director | 01-Aug-2024 | Current |
Bhagavatranga Gajjala  | Director | 09-Mar-2012 | Current |
| Sireesha Gajjala | Director | 21-Aug-2006 | Current |
Financial Performance and Corporate Structure Insights of Noven Life Sciences.
Noven Life Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.74% decrease. The company also saw a substantial improvement in profitability, with a 24.62% increase in profit. The company's net worth moved up by a moderate rise of 2.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noven Life Sciences?
Unlock access to Noven Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 01 Mar 2013 | ₹5.40 Cr | Open |
How Many Employees Work at Noven Life Sciences?
Unlock and access historical data on people associated with Noven Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noven Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noven Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
